165469161	165469161	CD	B-NP	O
|	|	NN	I-NP	O
NH	NH	NN	I-NP	O
|	|	NN	I-NP	O
87680508	87680508	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
102154	102154	CD	B-NP	O
|	|	CC	I-NP	O
2/26/1999	2/26/1999	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PANCREATITIS	PANCREATITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/25/1999	5/25/1999	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/20/1999	4/20/1999	CD	B-NP	O
IDENTIFICATION	IDENTIFICATION	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
40-year-old	40-year-old	JJ	I-NP	O
Hispanic	Hispanic	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mrs.	Mrs.	NNP	B-NP	O
Moehn	Moehn	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
40-year-old	40-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
with	with	IN	B-PP	O
HIV	HIV	NN	B-NP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
,	,	,	O	O
last	last	JJ	B-NP	B-protein
viral	viral	JJ	I-NP	I-protein
load	load	NN	I-NP	I-protein
was	be	VBD	B-VP	I-protein
2/3	2/3	CD	B-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
mid-epigastric	mid-epigastric	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Current	Current	JJ	B-NP	O
history	history	NN	I-NP	O
begins	begin	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
Mrs.	Mrs.	NNP	B-NP	O
Bizzard	Bizzard	NNP	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
Terskiff	Terskiff	NNP	B-NP	O
Anbing	Anbing	NNP	I-NP	O
Center	Center	NNP	I-NP	O
after	after	IN	B-PP	O
four	four	CD	B-NP	O
day	day	NN	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
records	record	NNS	I-NP	O
from	from	IN	B-PP	O
Envan	Envan	NNP	B-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
available	available	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
describes	describe	VBZ	B-VP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
endoscopy	endoscopy	NN	B-NP	O
performed	perform	VBN	B-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
gastritis	gastritis	NN	B-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Demerol	Demerol	NN	B-NP	O
and	and	CC	I-NP	O
morphine	morphine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
she	she	PRP	B-NP	O
awoke	awoke	VB	B-VP	O
this	this	DT	B-NP	O
morning	morning	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
good	good	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
about	about	IN	B-NP	O
30	30	CD	I-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
taking	take	VBG	B-VP	O
a	a	DT	B-NP	O
crushed	crushed	JJ	I-NP	O
tablet	tablet	NN	I-NP	O
of	of	IN	B-PP	O
DDI	DDI	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
experience	experience	VB	I-VP	O
severe	severe	JJ	B-NP	O
mid-epigastric	mid-epigastric	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
radiated	radiate	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quaddrant	quaddrant	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
took	take	VBD	B-VP	O
Maalox	Maalox	NN	B-NP	O
without	without	IN	B-PP	O
relief	relief	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Well	Well	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
and	and	CC	O	O
took	take	VBD	B-VP	O
her	her	PRP	B-NP	O
q.	q.	LS	B-LST	O
daily	daily	JJ	B-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
herself	herself	PRP	B-NP	O
to	to	TO	B-PP	O
Naco	Naco	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
stabbing	stab	VBG	I-NP	O
10/10	10/10	CD	I-NP	O
pain	pain	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
relationship	relationship	NN	I-NP	O
to	to	TO	B-PP	O
position	position	NN	B-NP	O
.	.	.	O	O

Nothing	Nothing	NN	B-NP	O
makes	make	VBZ	B-VP	O
it	it	PRP	B-NP	O
better	well	RBR	B-ADVP	O
.	.	.	O	O

It	It	PRP	B-NP	O
radiates	radiate	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	NN	I-NP	O
and	and	CC	I-NP	O
bores	bore	NNS	I-NP	O
straight	straight	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
back	back	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
exactly	exactly	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Restso	Restso	NNP	B-NP	O
Mao	Mao	NNP	I-NP	O
Angewhifirst	Angewhifirst	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
ALLERGIES	ALLERGIES	NNPS	I-NP	O
:	:	:	O	O
Compazine	Compazine	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
tardive	tardive	JJ	B-NP	O
dyskinesia	dyskinesia	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
DDI	DDI	NN	B-NP	O
;	;	:	O	O
d4t	d4t	NN	B-NP	O
,	,	,	O	O
Indinavir	Indinavir	NN	B-NP	O
,	,	,	O	O
Serax	Serax	NN	B-NP	O
;	;	:	O	O
hydroxyurea	hydroxyurea	NN	B-NP	O
;	;	:	O	O
Dilantin	Dilantin	NN	B-NP	O
,	,	,	O	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

q.d.	q.d.	LS	B-LST	O
;	;	:	O	O
Zoloft	Zoloft	NNP	B-NP	O
;	;	:	O	O
methadone	methadone	NN	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

q.d.	q.d.	LS	B-LST	O
;	;	:	O	O
Klonopin	Klonopin	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

q.i.d.	q.i.d.	LS	B-LST	O
;	;	:	O	O
Proventil	Proventil	NN	B-NP	O
;	;	:	O	O
Percocet	Percocet	NNP	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
.	.	.	O	O

Pancreatis	Pancreatis	NNP	B-NP	O
;	;	:	O	O
2	2	CD	B-NP	O
.	.	.	O	O

Peptic	Peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
;	;	:	O	O
3	3	LS	B-LST	O
.	.	.	O	O

HIV	HIV	NN	B-NP	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
;	;	:	O	O
4	4	CD	B-NP	O
.	.	.	O	O

Hepatitis	Hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
virus	virus	NN	I-NP	O
;	;	:	O	O
5	5	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
;	;	:	O	O
6	6	CD	B-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	B-protein
RPR	RPR	NN	I-NP	I-protein
and	and	CC	O	O
positive	positive	JJ	B-NP	O
MHATP	MHATP	NN	I-NP	O
in	in	IN	B-PP	O
9/19/98	9/19/98	CD	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
HIV	HIV	NN	B-NP	O
contact	contact	NN	I-NP	O
via	via	IN	B-PP	O
sexual	sexual	JJ	B-NP	O
intercourse	intercourse	NN	I-NP	O
;	;	:	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
heroine	heroine	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
beginning	begin	VBG	I-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
after	after	IN	B-PP	O
contracting	contract	VBG	B-VP	O
HIV	HIV	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
states	state	VBZ	B-VP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
over	over	IN	B-NP	O
five	five	CD	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
99.7	99.7	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
115	115	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
150/90	150/90	CD	I-NP	O
;	;	:	O	O
satting	satte	VBG	B-VP	O
at	at	IN	B-PP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
middle-aged	middle-aged	JJ	I-NP	O
Hispanic	Hispanic	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
writhing	writhe	VBG	I-VP	O
in	in	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
responsive	responsive	JJ	I-ADJP	O
.	.	.	O	O

Head	Head	NN	B-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Poor	Poor	NN	B-NP	O
dentitia	dentitia	NN	I-NP	O
,	,	,	O	O
pupils	pupil	VBZ	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Sclera	Sclera	NNP	B-NP	O
anicteric	anicteric	JJ	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
supple	supple	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
is	be	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
tachycardic	tachycardic	JJ	B-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
distended	distend	VBN	I-VP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epigastric	epigastric	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
to	to	TO	B-PP	O
light	light	NN	B-NP	O
palpation	palpation	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
to	to	TO	B-PP	O
lower	low	JJR	B-NP	O
abdomen	abdoman	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
Grey	Grey	NNP	I-NP	O
Turner	Turner	NNP	I-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibialis	tibialis	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
153	153	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.2	5.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
99	99	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
27	27	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
15	15	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.4	0.4	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
127	127	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
5.5	5.5	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
41.5	41.5	CD	I-NP	I-protein
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
count	count	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
,	,	,	O	O
MCV	MCV	NN	B-NP	B-cell_line
103.1	103.1	CD	I-NP	I-cell_line
,	,	,	O	O
RDW	RDW	NNP	B-NP	B-cell_line
17.0	17.0	CD	I-NP	I-cell_line
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
38	38	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	B-cell_line
113	113	CD	I-NP	I-cell_line
,	,	,	O	O
alk	alk	NN	B-NP	O
phos	pho	NNS	I-NP	O
13	13	CD	B-NP	O
,	,	,	O	O
amylase	amylase	NN	B-NP	O
307	307	CD	I-NP	O
,	,	,	O	O
lipase	lipase	NN	B-NP	O
3	3	CD	I-NP	O
,	,	,	I-NP	O
522	522	CD	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
bili	bili	NNS	I-NP	O
0.7	0.7	CD	B-NP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
bili	bili	NN	I-NP	O
0.4	0.4	CD	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
13.1	13.1	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
28.8	28.8	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
.	.	.	O	O

Urine	Urine	NN	B-NP	O
,	,	,	I-NP	O
HCG	HCG	NN	I-NP	O
negative	negative	JJ	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
enlarged	enlarged	JJ	I-NP	O
common	common	JJ	I-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
without	without	IN	B-PP	O
interhepatic	interhepatic	JJ	B-NP	O
dilatation	dilatation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
limited	limit	VBN	I-VP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
40-year-old	40-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
HIV	HIV	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Tieson	Tieson	NNP	I-NP	O
E	E	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
after	after	IN	B-PP	O
recent	recent	JJ	B-NP	O
discharge	discharge	NN	I-NP	O
from	from	IN	B-PP	O
Ot	Ot	NNP	B-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
second	second	JJ	B-NP	O
lifetime	lifetime	NN	I-NP	O
episode	episode	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
HIV	HIV	NN	I-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Mrs.	Mrs.	NNP	B-NP	O
Chisem	Chisem	NNP	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
General	General	NNP	I-NP	O
Medicine	Medicine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
Team	Team	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
immediately	immediately	RB	I-VP	O
placed	place	VBN	I-VP	O
NPO	NPO	NN	B-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	B-ADVP	O
fluid	fluid	NN	B-NP	O
hydrated	hydrate	VBN	B-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
morphine	morphine	NN	I-NP	O
PCA	PCA	NN	I-NP	O
pump	pump	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
seizure	seizure	NN	B-NP	O
disorders	disorder	NNS	I-NP	O
,	,	,	O	O
Demerol	Demerol	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
very	very	RB	B-ADVP	O
sparingly	sparingly	RB	I-ADVP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
only	only	RB	B-VP	O
used	use	VBN	I-VP	O
once	once	RB	B-ADVP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
mid-epigastric	mid-epigastric	JJ	B-NP	B-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
10/10	10/10	CD	B-NP	O
even	even	RB	B-ADVP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morphine	morphine	NN	I-NP	O
PCA	PCA	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Pain	Pain	NNP	I-NP	O
Service	Service	NNP	I-NP	O
changed	change	VBD	B-VP	O
her	her	PRP$	B-NP	O
over	over	RP	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
Dilaudid	Dilaudid	JJ	I-NP	O
PCA	PCA	NN	I-NP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
hungry	hungry	JJ	B-ADJP	O
and	and	CC	O	O
wanted	want	VBD	B-VP	O
to	to	TO	I-VP	O
eat	eat	VB	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
to	to	TO	B-PP	O
clear	clear	JJ	B-NP	O
sips	sip	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
advanced	advance	VBD	B-VP	O
to	to	TO	B-PP	O
full	full	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
Dilaudid	Dilaudid	NNP	I-NP	O
PCA	PCA	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Percocet	Percocet	NNP	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
pancreatic	pancreatic	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
of	of	IN	B-PP	O
3522	3522	CD	B-NP	O
down	down	IN	B-PP	O
to	to	TO	B-PP	O
1495	1495	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
to	to	TO	B-PP	O
1125	1125	CD	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
9/17	9/17	CD	B-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
682	682	CD	B-NP	O
;	;	:	O	O
by	by	IN	B-PP	O
5/8	5/8	CD	B-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
884	884	CD	B-NP	O
.	.	.	O	O

Triglycerides	Triglyceride	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
77	77	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
HIV	HIV	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
10/6	10/6	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
Percocet	Percocet	NNP	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
tolerating	tolerate	VBG	I-VP	O
p.o.s	p.o.	NNS	B-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
agitation	agitation	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
Klonopin	Klonopin	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
Klonopin	Klonopin	NN	B-NP	O
was	be	VBD	B-VP	O
reinstituted	reinstitute	VBN	I-VP	O
by	by	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
less	less	RBR	B-ADJP	O
agitated	agitate	VBN	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Dilantin	Dilantin	NN	B-NP	B-protein
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
;	;	:	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
seizure	seizure	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Dana	Dana	NNP	B-NP	O
Siegwarth	Siegwarth	NNP	I-NP	O
She	She	NNP	I-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
HIV	HIV	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
added	add	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
date	date	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
Team	Team	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
methadone	methadone	NN	I-NP	O
maintenance	maintenance	NN	I-NP	O
at	at	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
unaware	unaware	JJ	B-ADJP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
dosage	dosage	NN	I-NP	O
of	of	IN	B-PP	O
methadone	methadone	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Klonopin	Klonopin	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
;	;	:	O	O
methadone	methadone	NN	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dosage	dosage	NN	I-NP	O
of	of	IN	B-PP	O
methadone	methadone	NN	B-NP	O
;	;	:	O	O
Dilantin	Dilantin	NN	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-LST	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Zoloft	Zoloft	NNP	B-NP	O
,	,	,	O	O
75	75	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
;	;	:	O	O
Percocet	Percocet	NN	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tabs	tab	NNS	I-NP	B-protein
p.o.	p.o.	FW	I-NP	I-protein
q.	q.	FW	I-NP	I-protein
4-6	4-6	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
prn	prn	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Proventil	Proventil	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mcmurrin	Mcmurrin	NNP	I-NP	O
's	's	POS	B-NP	O
clinic	clinic	NN	I-NP	O
next	next	IN	B-NP	O
week	week	NN	I-NP	O
to	to	TO	B-VP	O
carefully	carefully	RB	I-VP	O
review	review	VB	I-VP	O
an	an	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
regiment	regiment	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
TYRON	TYRON	NNP	B-NP	O
HEINDEL	HEINDEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ME41	ME41	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
STEPHEN	STEPHEN	NNP	B-NP	O
J.	J.	NNP	I-NP	O
LAMPEY	LAMPEY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CB22	CB22	NNP	I-NP	O
KO036/9362	KO036/9362	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
57037	57037	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

BNPVKG01EL	BNPVKG01EL	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/24/99	11/24/99	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/6/99	7/6/99	CD	B-NP	O
cc	cc	NN	I-NP	O
:	:	:	O	O
Fermin	Fermin	NNP	B-NP	O
Sliker	Sliker	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O

